Biosimilars of biological drug therapies: regulatory, clinical and commercial considerations. (Q30406304)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Biosimilars of biological drug therapies: regulatory, clinical and commercial considerations.
scientific article

    Statements

    Biosimilars of biological drug therapies: regulatory, clinical and commercial considerations (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit